Description of Brivaracetam purchasing channels and formal channels

Brivaracetam/Brivaracetam is a new type of anti-epileptic drug, mainly used to treat partial-onset epilepsy in adults. It has the characteristics of high selectivity and good tolerance. However, access to the drug in the domestic market remains limited. According to the latest information, the original drug of Brivaracetam has not yet been officially launched in China, so domestic patients are temporarily unable to purchase it directly through regular hospital or pharmacy channels. For patients who want to use this drug, they need to fully understand the formal access channels and relevant legal regulations to avoid purchasing unapproved drugs or channels with quality risks.

In overseas markets, Brivaracetam has been launched in Europe, the United States and other countries. The original drug specification is usually 50mg*60 tablets. In the European market, patients can purchase it through prescription drug channels. The price is affected by exchange rates and regional policies, and is about more than 4,000 yuan per bottle. It should be noted that overseas drug purchases usually require a doctor's prescription and are carried out through regular pharmacies or medical institutions. It is not recommended to purchase through informal channels to avoid risks caused by the authenticity of the drugs, unqualified transportation conditions and customs policy restrictions.

Currently, there are no generic versions of Brivaracetam available overseas, which means that patients who wish to use the drug must rely on the original version. When prescribing, clinicians will also consider the patient's previous medication history, disease type and tolerance to evaluate its applicability and efficacy potential. In addition, overseas guidelines emphasize that when patients purchase or import drugs across borders, they should fully understand the transportation and storage conditions to ensure that the drugs are used within the validity period and in the correct storage state to maximize safety and efficacy.

For domestic patients, other approved anti-epileptic drugs can be used clinically for basic control. At the same time, they can consult on the feasibility of cross-border drug purchase through formal channels and use them rationally under the guidance of professional doctors.

Reference materials:https://www.briviact.com/